Effect of Citalopram on Health status, anxiety and depression in patients with chronic Obstructive pulmonary disease: a pilot study

Not Applicable

Completed

• Conditions: Chronic obstructive pulmonary disease (COPD); Respiratory; Pulmonary diseases

• Registration Number: ISRCTN41544517
• Lead Sponsor: orth East Wales NHS Trust (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2008-04-21
• Last Update Posted: 30 October 2017

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

1. Diagnosis of COPD
2. Clinical diagnosis of anxiety or depression
3. Adults of either sex

Exclusion Criteria

1. Severe ischaemic heart disease
2. On treatment for anxiety or depression
3. Terminal illness

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Health-related quality of life, measured using St Georges Respiratory Questionnaire at baseline and 3 months

Secondary Outcome Measures

Name	Time	Method
1. Depression and anxiety, measured using the Hospital Anxiety and Depression Score (HADS) at baseline and 3 months<br>2. Depression and anxiety, measured using the Depression in Medical Illness, a 10-item questionnaire (DM-10) at baseline and 3 months<br><br>Additionally at baseline, 1, 2 and 3 months a structured side effect profile was checked.